久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/10 | 3,890 | 3,905 | 3,850 | 3,860 | ±0 | ±0% | 249,800 |
2021/11/09 | 3,865 | 3,900 | 3,840 | 3,860 | ±0 | ±0% | 268,700 |
2021/11/08 | 3,925 | 3,940 | 3,855 | 3,860 | -65 | -1.7% | 230,800 |
2021/11/05 | 3,915 | 3,930 | 3,855 | 3,925 | -5 | -0.1% | 334,400 |
2021/11/04 | 4,050 | 4,055 | 3,915 | 3,930 | -70 | -1.8% | 439,200 |
2021/11/02 | 4,045 | 4,045 | 3,985 | 4,000 | -45 | -1.1% | 339,900 |
2021/11/01 | 3,940 | 4,050 | 3,925 | 4,045 | +175 | +4.5% | 316,100 |
2021/10/29 | 3,985 | 3,985 | 3,865 | 3,870 | -85 | -2.1% | 410,100 |
2021/10/28 | 3,970 | 4,005 | 3,955 | 3,955 | -65 | -1.6% | 823,400 |
2021/10/27 | 4,060 | 4,100 | 3,985 | 4,020 | +25 | +0.6% | 447,800 |
2021/10/26 | 4,060 | 4,060 | 3,985 | 3,995 | -30 | -0.7% | 292,900 |
2021/10/25 | 4,010 | 4,065 | 3,995 | 4,025 | -55 | -1.3% | 310,100 |
2021/10/22 | 4,045 | 4,100 | 4,030 | 4,080 | -25 | -0.6% | 198,800 |
2021/10/21 | 4,140 | 4,160 | 4,080 | 4,105 | -90 | -2.1% | 334,800 |
2021/10/20 | 4,195 | 4,270 | 4,170 | 4,195 | +45 | +1.1% | 293,900 |
2021/10/19 | 4,170 | 4,205 | 4,130 | 4,150 | +15 | +0.4% | 301,300 |
2021/10/18 | 4,325 | 4,335 | 4,130 | 4,135 | -115 | -2.7% | 461,300 |
2021/10/15 | 4,250 | 4,315 | 4,225 | 4,250 | +255 | +6.4% | 742,900 |
2021/10/14 | 3,940 | 4,035 | 3,895 | 3,995 | +35 | +0.9% | 428,000 |
2021/10/13 | 3,975 | 4,025 | 3,955 | 3,960 | -15 | -0.4% | 447,800 |
2021/10/12 | 4,100 | 4,110 | 3,960 | 3,975 | -160 | -3.9% | 414,700 |
2021/10/11 | 4,110 | 4,185 | 4,090 | 4,135 | +10 | +0.2% | 239,900 |
2021/10/08 | 4,085 | 4,150 | 4,075 | 4,125 | +110 | +2.7% | 323,300 |
2021/10/07 | 4,070 | 4,070 | 4,005 | 4,015 | -55 | -1.4% | 305,600 |
2021/10/06 | 4,065 | 4,135 | 4,040 | 4,070 | ±0 | ±0% | 229,300 |
2021/10/05 | 4,170 | 4,190 | 4,045 | 4,070 | -130 | -3.1% | 443,700 |
2021/10/04 | 4,240 | 4,250 | 4,180 | 4,200 | +30 | +0.7% | 301,100 |
2021/10/01 | 4,175 | 4,210 | 4,120 | 4,170 | -75 | -1.8% | 334,500 |
2021/09/30 | 4,225 | 4,320 | 4,220 | 4,245 | +15 | +0.4% | 305,100 |
2021/09/29 | 4,175 | 4,230 | 4,155 | 4,230 | +10 | +0.2% | 312,200 |
2021/09/28 | 4,235 | 4,260 | 4,190 | 4,220 | -60 | -1.4% | 321,100 |
2021/09/27 | 4,415 | 4,440 | 4,280 | 4,280 | -115 | -2.6% | 240,600 |
2021/09/24 | 4,320 | 4,410 | 4,320 | 4,395 | +145 | +3.4% | 373,800 |
2021/09/22 | 4,325 | 4,325 | 4,235 | 4,250 | -95 | -2.2% | 287,200 |
2021/09/21 | 4,380 | 4,395 | 4,340 | 4,345 | -70 | -1.6% | 264,100 |
2021/09/17 | 4,465 | 4,485 | 4,380 | 4,415 | +20 | +0.5% | 393,600 |
2021/09/16 | 4,440 | 4,440 | 4,375 | 4,395 | -5 | -0.1% | 227,100 |
2021/09/15 | 4,460 | 4,475 | 4,400 | 4,400 | -120 | -2.7% | 298,400 |
2021/09/14 | 4,515 | 4,530 | 4,480 | 4,520 | +5 | +0.1% | 206,200 |
2021/09/13 | 4,500 | 4,520 | 4,470 | 4,515 | +5 | +0.1% | 151,600 |
2021/09/10 | 4,515 | 4,535 | 4,465 | 4,510 | -25 | -0.6% | 293,100 |
2021/09/09 | 4,630 | 4,645 | 4,530 | 4,535 | -90 | -1.9% | 232,300 |
2021/09/08 | 4,620 | 4,675 | 4,600 | 4,625 | +20 | +0.4% | 249,000 |
2021/09/07 | 4,630 | 4,655 | 4,590 | 4,605 | +5 | +0.1% | 208,500 |
2021/09/06 | 4,675 | 4,700 | 4,560 | 4,600 | -10 | -0.2% | 260,400 |
2021/09/03 | 4,480 | 4,625 | 4,470 | 4,610 | +180 | +4.1% | 311,900 |
2021/09/02 | 4,470 | 4,515 | 4,405 | 4,430 | -35 | -0.8% | 235,500 |
2021/09/01 | 4,500 | 4,545 | 4,420 | 4,465 | +55 | +1.2% | 279,500 |
2021/08/31 | 4,380 | 4,445 | 4,330 | 4,410 | -5 | -0.1% | 293,500 |
2021/08/30 | 4,460 | 4,485 | 4,390 | 4,415 | -70 | -1.6% | 551,800 |
851~
900
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム